ArcticZymes Technologies ASA (LON: 0DRV)

Market Cap	51.48M
Revenue (ttm)	7.85M
Net Income (ttm)	327.91K
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	157.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,093
Average Volume	701
Open	14.32
Previous Close	n/a
Day's Range	14.32 - 14.32
52-Week Range	0.92 - 2.90
Beta	0.97
RSI	40.81
Earnings Date	Feb 13, 2025

About ArcticZymes Technologies ASA

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, rest of Europe, the United States, and internationally. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; salt active nuclease for the removal of nucleic acids during man...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1990
• Employees: 61
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DRV

Financial Performance

In 2023, ArcticZymes Technologies ASA's revenue was 119.65 million, a decrease of -13.09% compared to the previous year's 137.67 million. Earnings were 19.43 million, a decrease of -40.89%.

Financial numbers in NOK